$BLND Cashflow Statement | Understand Stock

$BLND

$1.16 +$0.00 (0.0%) Close

$BLND Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Less: Net loss from discontinued operations
Net loss from continuing operations
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Impairment of intangible assets and goodwill
Amortization of deferred contract costs
Amortization of debt discount and issuance costs
Interest on discount on convertible note
Amortization of operating lease right-of-use assets
Accelerated amortization of right-of-use asset in connection with lease abandonment
Gain on conversion of note receivable to investment in equity securities
Gain on investment in equity securities
Loss on extinguishment of debt
Gain on sale of insurance business
Release of valuation allowance and change in deferred taxes
Other
Changes in operating assets and liabilities:
Trade and other receivables
Prepaid expenses and other assets, current and non-current
Deferred contract costs, non-current
Accounts payable
Deferred revenue
Accrued compensation
Operating lease liabilities
Other liabilities, current and non-current

Net cash provided by (used in) operating activities - continuing operations
Net cash used in operating activities - discontinued operations
Net cash provided by (used in) operating activities
Investing activities
Purchases of marketable securities
Sale of available-for-sale securities
Maturities of marketable securities
Purchases of property and equipment
Additions to property, equipment and internal-use software development costs
Proceeds from sale of insurance business
Cash received in connection with conversion of note receivable to investment in equity securities
Investment in non-marketable equity securities
Investment in note receivable
Acquisition of Title365, net of cash acquired
Capitalization of internal-use software
Purchases of intangible assets
Other
Net cash provided by investing activities - continuing operations
Net cash used in investing activities - discontinued operations
Net cash provided by investing activities

Financing activities
Proceeds from exercises of stock options, including early exercises, net of repurchases
Proceeds from exercises of common stock warrants
Taxes paid related to net share settlement of equity awards
Share repurchases
Repayment of long-term debt
Proceeds from issuance of Convertible Preferred Stock, net of issuance costs
Proceeds from exercises of Convertible Preferred Stock warrants
Proceeds from repayment of employee promissory note collateralized by common stock
Proceeds from convertible debt
Proceeds from exercises of Series D Convertible Preferred Stock warrants
Other
Net proceeds from the issuance of the Series A redeemable convertible preferred stock and the Haveli Warrant
Payment for issuance costs related to the Series A redeemable convertible preferred stock and the Haveli Warrant
Proceeds from initial public offering, net of underwriters' fees and issuance costs
Proceeds from debt financing, net of issuance costs
Repurchases of unvested early exercised stock options
Net cash used in financing activities - continuing operations

Effect of exchange rates on cash, cash equivalents, and restricted cash
Net (decrease) increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Less: Cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations
Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for income taxes
State and local
Foreign
Total income taxes paid, net
Cash paid for interest
Supplemental disclosure of non-cash investing and financing activities:
Deferred offering costs not yet paid
Conversion of note receivable to investment in equity securities
Reclassification of redeemable noncontrolling interest related to discontinued operations to equity
Vesting of early exercised stock options
Operating lease liabilities arising from obtaining new or modified right-of-use assets
Exercise of Series D Convertible Preferred Stock warrants included in prepaid expenses and other current assets
Stock-based compensation included in capitalized internal-use software development costs
Accretion of redeemable noncontrolling interest related to discontinued operations to redemption value
Accretion of Series A redeemable convertible preferred stock to redemption value
Issuance of warrant in connection with debt financing
Covered Warrant received in connection with strategic partnership and sale of insurance business
Capitalized internal-use software development costs included in accrued compensation

Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets:
Cash and cash equivalents
Restricted cash

Comments